White House nears deal to lower obesity drug prices for Medicare coverage
The GLP-1 drugs, produced by Novo Nordisk and Eli Lilly, have been credited with helping weight-loss, preventing diabetes and other positive effects.
View original article
Contributor: Dan Diamond, Rachel Roubein
